CDK9 INHIBITORS: a promising combination partner in the treatment of hematological malignancies
Home | Publication | CDK9 INHIBITORS: a promising combination partner in the treatment of hematological malignancies
Publications
75
+
Clinical Trials Ran
0
+
Approved Therapies
0